13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001882053
Total reported value
$427.5M
$427.5M
17 檔
46.3%
During the Q3 2024 filing period, Boone Capital Management LLC (CIK: 0001882053) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $427.5M across 17 reported positions.
In Q3 2024, Boone Capital Management LLC adopted a defensive or profit-taking posture, trimming 8 positions and completely liquidating 4 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UNM | Unum Group | Stock-Financials | 14.86% | — | +3.61% | |
| 2 | GMED | Globus Medical Inc - A | Stock-Healthcare | 12.09% | — | +2.26% | |
| 3 | CI | THE Cigna Group | Stock-Healthcare | 11.85% | -0.97% | — | |
| 4 | MOH | Molina Healthcare Inc | Stock-Healthcare | 6.40% | — | -27.64% | |
| 5 | CHE | Chemed CORP | Stock-Healthcare | 6.14% | — | — | |
| 6 | PNTG | Pennant Group Inc/the | Stock-Other | 5.93% | +4.46% | NEW | |
| 7 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 5.50% | -0.54% | +3.85% | |
| 8 | DHR | Danaher CORP | Stock-Healthcare | 4.42% | — | -42.34% | |
| 9 | IDYA | Ideaya Biosciences Inc | Stock-Other | 4.37% | — | +25.96% | |
| 10 | BAX | Baxter International Inc | Stock-Healthcare | 4.35% | — | -38.74% | |
| 11 | BERYEUR | Berry Global Group Inc | Stock-Other | 4.32% | — | -5.67% | |
| 12 | IQV | Iqvia Holdings Inc | Stock-Healthcare | 4.15% | — | -28.66% | |
| 13 | AMPH | Amphastar Pharmaceuticals In | Stock-Other | 3.98% | — | -36.06% | |
| 14 | OFIX | Orthofix Medical Inc | Stock-Other | 3.77% | — | +20.01% | |
| 15 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 3.17% | — | +10.37% | |
| 16 | PRGO | Perrigo Company plc | Stock-Healthcare | 3.07% | — | — | |
| 17 | CERT | Certara Inc | Stock-Other | 1.64% | — | -24.64% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CHE | Chemed CORP | +6.1% | NEW | New buy |
| 2 | PRGO | Perrigo Company plc | +3.1% | NEW | New buy |
| 3 | UNM | Unum Group | +2.5% | +3.61% | Add |
| 4 | PNTG | Pennant Group Inc/the | +1.7% | -8.39% | Trim |
| 5 | OFIX | Orthofix Medical Inc | +1.1% | +20.01% | Add |
| 6 | MIRM | Mirum Pharmaceuticals Inc | +0.8% | +3.85% | Add |
| 7 | VKTX | Viking Therapeutics Inc | +0.8% | +10.37% | Add |
| 8 | GMED | Globus Medical Inc - A | +0.7% | +2.26% | Add |
| 9 | IDYA | Ideaya Biosciences Inc | +0.5% | +25.96% | Add |
| 10 | CI | THE Cigna Group | +0.5% | — | Unchanged |
| 11 | BERYEUR | Berry Global Group Inc | +0.3% | -5.67% | Trim |
| 12 | CERT | Certara Inc | -1% | -24.64% | Trim |
| 13 | IQV | Iqvia Holdings Inc | -1.1% | -28.66% | Trim |
| 14 | AMPH | Amphastar Pharmaceuticals In | -1.2% | -36.06% | Trim |
| 15 | MOH | Molina Healthcare Inc | -1.3% | -27.64% | Trim |
| 16 | TARS | Tarsus Pharmaceuticals Inc | -1.5% | EXIT | Sold out |
| 17 | BAX | Baxter International Inc | -1.9% | -38.74% | Trim |
| 18 | HCSG | Healthcare Services Group | -2.4% | EXIT | Sold out |
| 19 | DHR | Danaher CORP | -2.5% | -42.34% | Trim |
| 20 | XENE | Xenon Pharmaceuticals Inc | -2.6% | EXIT | Sold out |
| 21 | CRL | Charles River Laboratories | -2.6% | EXIT | Sold out |
According to official SEC Form 13F filings, Boone Capital Management LLC reported a total U.S. public equity portfolio value of $427.5M across 17 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including UNM, GMED, CI) accounted for 46.3% of total reported equity market value during Q3 2024.
Top New Position Initiated
CHE
市值: $23.7M
Top Position Liquidated / Trimmed
CRL
前期市值: $10.0M
During Q3 2024, Boone Capital Management LLC's top holdings by market value included UNM (14.9%)、GMED (12.1%)、CI (11.8%). The largest single position, UNM, represented 14.9% of total portfolio value.
In Q3 2024, Boone Capital Management LLC made 20 total portfolio adjustments, initiating 2 new buys, adding to 6 positions, trimming 8 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.